Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
LASSO regression
Oxidative phosphorylation (OXPHOS)
Prognostic risk score model
Uveal melanoma (UVM)
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
02 May 2024
02 May 2024
Historique:
received:
27
12
2022
accepted:
09
04
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
2
5
2024
Statut:
epublish
Résumé
Uveal melanoma (UVM) is a malignant intraocular tumor in adults. Targeting genes related to oxidative phosphorylation (OXPHOS) may play a role in anti-tumor therapy. However, the clinical significance of oxidative phosphorylation in UVM is unclear. The 134 OXPHOS-related genes were obtained from the KEGG pathway, the TCGA UVM dataset contained 80 samples, served as the training set, while GSE22138 and GSE39717 was used as the validation set. LASSO regression was carried out to identify OXPHOS-related prognostic genes. The coefficients obtained from Cox multivariate regression analysis were used to calculate a risk score, which facilitated the construction of a prognostic model. Kaplan-Meier survival analysis, logrank test and ROC curve using the time "timeROC" package were conducted. The immune cell frequency in low- and high-risk group was analyzed through Cibersort tool. The specific genomic alterations were analyzed by "maftools" R package. The differential expressed genes between low- or high-risk group were analyzed and performed Gene Ontology (GO) and GSEA. Finally, we verified the function of CYC1 in UVM by gene silencing in vitro. A total of 9 OXPHOS-related prognostic genes were identified, including NDUFB1, NDUFB8, ATP12A, NDUFA3, CYC1, COX6B1, ATP6V1G2, ATP4B and NDUFB4. The UVM prognostic risk model was constructed based on the 9 OXPHOS-related prognostic genes. The prognosis of patients in the high-risk group was poorer than low-risk group. Besides, the ROC curve demonstrated that the area under the curve of the model for predicting the 1 to 5-year survival rate of UVM patients were all more than 0.88. External validation in GSE22138 and GSE39717 dataset revealed that these 9 genes could also be utilized to evaluate and predict the overall survival of patients with UVM. The risk score levels related to immune cell frequency and specific genomic alterations. The DEGs between the low- and high- risk group were enriched in tumor OXPHOS and immune related pathway. In vitro experiments, CYC1 silencing significantly inhibited UVM cell proliferation and invasion, induced cell apoptosis. In sum, a prognostic risk score model based on oxidative phosphorylation-related genes in UVM was developed to enhance understanding of the disease. This prognostic risk score model may help to find potential therapeutic targets for UVM patients. CYC1 acts as an oncogene role in UVM.
Sections du résumé
BACKGROUND
BACKGROUND
Uveal melanoma (UVM) is a malignant intraocular tumor in adults. Targeting genes related to oxidative phosphorylation (OXPHOS) may play a role in anti-tumor therapy. However, the clinical significance of oxidative phosphorylation in UVM is unclear.
METHOD
METHODS
The 134 OXPHOS-related genes were obtained from the KEGG pathway, the TCGA UVM dataset contained 80 samples, served as the training set, while GSE22138 and GSE39717 was used as the validation set. LASSO regression was carried out to identify OXPHOS-related prognostic genes. The coefficients obtained from Cox multivariate regression analysis were used to calculate a risk score, which facilitated the construction of a prognostic model. Kaplan-Meier survival analysis, logrank test and ROC curve using the time "timeROC" package were conducted. The immune cell frequency in low- and high-risk group was analyzed through Cibersort tool. The specific genomic alterations were analyzed by "maftools" R package. The differential expressed genes between low- or high-risk group were analyzed and performed Gene Ontology (GO) and GSEA. Finally, we verified the function of CYC1 in UVM by gene silencing in vitro.
RESULTS
RESULTS
A total of 9 OXPHOS-related prognostic genes were identified, including NDUFB1, NDUFB8, ATP12A, NDUFA3, CYC1, COX6B1, ATP6V1G2, ATP4B and NDUFB4. The UVM prognostic risk model was constructed based on the 9 OXPHOS-related prognostic genes. The prognosis of patients in the high-risk group was poorer than low-risk group. Besides, the ROC curve demonstrated that the area under the curve of the model for predicting the 1 to 5-year survival rate of UVM patients were all more than 0.88. External validation in GSE22138 and GSE39717 dataset revealed that these 9 genes could also be utilized to evaluate and predict the overall survival of patients with UVM. The risk score levels related to immune cell frequency and specific genomic alterations. The DEGs between the low- and high- risk group were enriched in tumor OXPHOS and immune related pathway. In vitro experiments, CYC1 silencing significantly inhibited UVM cell proliferation and invasion, induced cell apoptosis.
CONCLUSION
CONCLUSIONS
In sum, a prognostic risk score model based on oxidative phosphorylation-related genes in UVM was developed to enhance understanding of the disease. This prognostic risk score model may help to find potential therapeutic targets for UVM patients. CYC1 acts as an oncogene role in UVM.
Identifiants
pubmed: 38698303
doi: 10.1186/s12886-024-03441-6
pii: 10.1186/s12886-024-03441-6
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
204Subventions
Organisme : Startup Fund for scientific research, Fujian Medical University
ID : 2019QH1182
Organisme : Natural Science Foundation Of Fujian Province
ID : 2021J01387
Informations de copyright
© 2024. The Author(s).
Références
Roland, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72(7):2219–23.
doi: 10.1002/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J
Niederkorn JY. Immune escape mechanisms of intraocular tumors. Progress Retinal Eye Res. 2009;28(5):329–47.
doi: 10.1016/j.preteyeres.2009.06.002
Wei-Min HE, Luo QL, Guo XW. Histopathological analysis on 622 cases of Orbitopathy. West China Medical Journal; 2002.
Singh AD, Turell ME, Topham AK. Uveal melanoma: Trends in Incidence, Treatment, and Survival. Ophthalmology. 2011;118(9):1881–5.
doi: 10.1016/j.ophtha.2011.01.040
pubmed: 21704381
Hanna, et al. Incidence of Uveal Malignant Melanoma. American Journal of Ophthalmology; 1979.
Woodman SE. Metastatic uveal melanoma: Biology and emerging treatments. Cancer J. 2012;18(2):148.
doi: 10.1097/PPO.0b013e31824bd256
pubmed: 22453016
pmcid: 3935729
Emine K, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Investig Ophthalmol Vis Sci. 2005;46(7):2253.
doi: 10.1167/iovs.04-1460
Noter SL, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res. 2004;14(1):67–72.
doi: 10.1097/00008390-200402000-00011
pubmed: 15091197
Lenn T, Leake MC, Mullineaux CW. Are Escherichia coli OXPHOS complexes concentrated in specialized zones within the plasma membrane? Biochem Soc Trans. 2008;36(5):1032–6.
doi: 10.1042/BST0361032
pubmed: 18793184
Tuppen H, et al. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 2010;1797(2):113–28.
doi: 10.1016/j.bbabio.2009.09.005
pubmed: 19761752
Rodríguez-Enríquez S, et al. Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol. 2010;216(1):189–97.
doi: 10.1002/jcp.21392
Ashton T, et al. Oxidative phosphorylation as an emerging target in Cancer Therapy. Clin cancer Research: Official J Am Association Cancer Res. 2018;24(11):2482–90.
doi: 10.1158/1078-0432.CCR-17-3070
Kuntz E, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017;23(10):1234–40.
doi: 10.1038/nm.4399
pubmed: 28920959
pmcid: 5657469
Zhang L et al. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med, 2019. 11(491).
Lai Y et al. Pyruvate kinase M2 expression: a potential metabolic biomarker to Differentiate Endometrial Precancer and Cancer that is Associated with Poor outcomes in Endometrial Carcinoma. Int J Environ Res Public Health, 2019. 16(23).
Chen W, et al. Identification and validation of Immune-related gene prognostic signature for Hepatocellular Carcinoma. J Immunol Res. 2020;2020:5494858.
doi: 10.1155/2020/5494858
pubmed: 32211443
pmcid: 7081044
Bai J, et al. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2022;150(2):352–e3617.
doi: 10.1016/j.jaci.2022.02.029
pubmed: 35305978
pmcid: 9378510
Yuan Q, et al. Identification of the Real Hub Gene and construction of a Novel Prognostic signature for pancreatic adenocarcinoma based on the Weighted Gene Co-expression Network Analysis and least Absolute Shrinkage and Selection Operator algorithms. Front Genet. 2021;12:692953.
doi: 10.3389/fgene.2021.692953
pubmed: 34490033
pmcid: 8417717
Liu J, et al. An Integrated TCGA Pan-cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018;173(2):400–e41611.
doi: 10.1016/j.cell.2018.02.052
pubmed: 29625055
pmcid: 6066282
Laurent C, et al. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 2011;71(3):666–74.
doi: 10.1158/0008-5472.CAN-10-0605
pubmed: 21135111
Hans C. Model uncertainty and variable selection in bayesian lasso regression. Stat Comput. 2010;20(2):221–9.
doi: 10.1007/s11222-009-9160-9
Barker C, Salama A. New NCCN guidelines for Uveal Melanoma and Treatment of recurrent or progressive distant metastatic melanoma. J Natl Compr Cancer Network: JNCCN. 2018;16:646–50.
doi: 10.6004/jnccn.2018.0042
Wan Q, et al. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma. Exp Eye Res. 2018;166:13–20.
doi: 10.1016/j.exer.2017.10.007
pubmed: 29031853
Luo H, et al. Prognostic implications of Novel ten-gene signature in Uveal Melanoma. Front Oncol. 2020;10:567512.
doi: 10.3389/fonc.2020.567512
pubmed: 33194647
pmcid: 7661968
Luo H, Ma C. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma Diagnostics (Basel, Switzerland), 2021. 11(2).
Heuvel L, Smeitink J. The oxidative phosphorylation (OXPHOS) system: nuclear genes and human genetic diseases. BioEssays. 2001;23(6):518–25.
doi: 10.1002/bies.1071
pubmed: 11385631
Caroline, et al. Choosing between glycolysis and oxidative phosphorylation: A tumor’s dilemma? Biochimica Et Biophysica Acta Bioenergetics; 2011.
Oxidative phosphorylation as a target to arrest malignant neoplasias. Curr Med Chem, 2011. 18(21): p.–.
Ashton TM et al. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res, 2018: p. clincanres.3070.2017.
Feng Z, et al. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. Nature chemical biology; 2022.
Ellinger J, et al. Systematic Expression Analysis of Mitochondrial Complex I identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma. Clin Genitourin Cancer. 2017;15(4):e551–62.
doi: 10.1016/j.clgc.2016.11.010
pubmed: 28063846
Wang K, et al. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients. Clin Transl Oncol. 2021;23(11):2368–81.
doi: 10.1007/s12094-021-02638-1
pubmed: 34028782
Chang Z, Miao X, Zhao W. Identification of prognostic dosage-sensitive genes in Colorectal Cancer based on Multi-omics. Front Genet. 2019;10:1310.
doi: 10.3389/fgene.2019.01310
pubmed: 31998369
Song Y, et al. Screening of potential biomarkers for gastric Cancer with Diagnostic Value using label-free Global Proteome Analysis. Volume 18. Genomics, proteomics & bioinformatics; 2020. pp. 679–95. 6.
Ma J et al. Genome-wide methylation profiling reveals new biomarkers for prognosis prediction of glioblastoma. J Cancer Res Ther, 2015: p. C212–5.
Raja U, Gopal G, Rajkumar T. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker. Asian Pac J cancer Prevention: APJCP. 2012;13(11):5563–8.
doi: 10.7314/APJCP.2012.13.11.5563
Qi C, et al. Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations. Cell Cycle (Georgetown Tex). 2022;21(12):1294–315.
doi: 10.1080/15384101.2022.2049157
pubmed: 35266851
Gao X, et al. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma. Sci Rep. 2022;12(1):12854.
doi: 10.1038/s41598-022-17308-7
pubmed: 35896732
pmcid: 9329323
Streif D, et al. Expression of the non-gastric H+/K + ATPase ATP12A in normal and pathological human prostate tissue. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2011;28(6):1287–94.
doi: 10.1159/000335860
Choi S, et al. Novel prognostic factor for Uveal Melanoma: Bioinformatics Analysis of three independent cohorts. Anticancer Res. 2020;40(7):3839–46.
doi: 10.21873/anticanres.14373
pubmed: 32620623
Whiteside, L T. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–12.
doi: 10.1038/onc.2008.271
pubmed: 18836471
pmcid: 3689267
Liao C, et al. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma. Int J Ophthalmol. 2021;14(8):1151–9.
doi: 10.18240/ijo.2021.08.03
pubmed: 34414077
pmcid: 8342279
Wang Y, et al. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Exp Eye Res. 2020;196:108069.
doi: 10.1016/j.exer.2020.108069
pubmed: 32439398
Sun Y, et al. Construction of a Promising Tumor-infiltrating CD8 + T Cells Gene Signature to improve prediction of the prognosis and Immune Response of Uveal Melanoma. Front Cell Dev Biology. 2021;9:673838.
doi: 10.3389/fcell.2021.673838
Johansson J, et al. Presence of tumor-infiltrating CD8 T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis. Oncoimmunology. 2020;9(1):1854519.
doi: 10.1080/2162402X.2020.1854519
pubmed: 33344043
pmcid: 7733984
Chang Q, et al. The IL-6/JAK/Stat3 feed-Forward Loop drives tumorigenesis and metastasis. Neoplasia; 2013.
Li R, Huang Y, Lin J. Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models. Nat Commun. 2020;11(1):642.
doi: 10.1038/s41467-019-14065-6
pubmed: 32005799
pmcid: 6994546
Ricoult SJH, Manning BD. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep. 2013;14(3):242–51.
doi: 10.1038/embor.2013.5
pubmed: 23399656
undefined u et al. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma 2020. 9.
Li G et al. CYC1 silencing sensitizes osteosarcoma cells to TRAIL-induced apoptosis. 2014. 34(6): p. 2070–80.